DOCSLIB.ORG

HDR Kadlec.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
HDR Kadlec.Pdf Structural and functional studies on epigenetic regulators Jan Kadlec To cite this version: Jan Kadlec. Structural and functional studies on epigenetic regulators. Biomolecules [q-bio.BM]. Université Grenoble Alpes, 2017. tel-02440134 HAL Id: tel-02440134 https://hal.univ-grenoble-alpes.fr/tel-02440134 Submitted on 15 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Structural and functional studies on epigenetic regulators Habilitation à diriger des recherches Spécialité: Biologie Jan KADLEC UNIVERSITE GRENOBLE ALPES 2017 ! Date de soutenance : 9 Mars 2017 ECOLE DOCTORALE DE CHIMIE ET SCIENCES DU VIVANT UNIVERSITE GRENOBLE ALPES HABILITATION A DIRIGER DES RECHERCHES Jan KADLEC Title: Structural and functional studies on epigenetic regulators Jury: Prof. Marc Jamin Rapporteur! Dr. Christophe Romier ! Rapporteur Dr. Sbastien Fribourg! Rapporteur Prof. Thomas Schalch ! Examinateur Dr. André Verdel ! Examinateur Institut de Biologie Structurale, Grenoble! Summary This manuscript describes my research activities over the last fifteen years. I graduated in Molecular Biology from the Charles University in Prague in 2000. At that time, structural biology was very poorly developed in my home country. During my training at EMBL in Grenoble I discovered for the first time the world of protein structures and realized how important detailed structural information can be to understand protein function. I then joined the laboratory of Stephen Cusack at the EMBL and began my PhD jointly with the Université Joseph Fourier. I started using X-ray crystallography and studied proteins involved in targeted mRNA degradation pathway called the Nonsense Mediated mRNA Decay. For my postdoc I decided to change the research filed and joined the group of David Stuart at the University of Oxford to work on viral fusion proteins. The preparation of these viral surface glycoproteins for crystallization required their expression in mammalian cells and an efficient deglycosylation. The scientific, instrumentation and technological environment at the department was truly exceptional so it was possible to succeed in these projects in a relatively short time. The structure of the baculovirus fusion protein GP64 we determined was perhaps the most revealing structure I have worked on so far and was a significant contribution to the viral fusion field. While working in Oxford was a great experience I decided to return to France and was offered a staff scientist position back at EMBL Grenoble in my original PhD laboratory. I was very fortunate to be given a maximal scientific independence and support within the group. I established a new research line in the group focusing on epigenetic regulatory complexes. Chromatin/epigenetic control of DNA-based processes is an extremely important and sophisticated layer of regulation. Perhaps, due to the challenging nature of chromatin regulatory complexes for structural analysis, most of them still remain structurally uncharacterised. I started two very fruitful collaborations with expert cell biologist in the chromatin field, Asifa Akhtar (MPI Freiburg) and Bernard de Massy (IGH Montpellier). Together with them we can carry out an interdisciplinary research combining biochemistry, structural and cell biology and genetics. All my work on the histone acetyltransferase complexes (MSL and NSL complex) and PRDM9 at the EMBL included supervision of Master and PhD students. In 2014, I obtained the ATIP/AVENIR start-up grant and moved to the Institut de Biologie Structurale (IBS) in Grenoble where I set up my research team. We continue our effort to structurally and functionally characterise the MSL and NSL complexes as well as the PRDM9 methyltransferase. Given the large size of these complexes, the method of choice for the analysis will be a combination of X-ray crystallography and cryo-electron microscopy. ! Table of contents I. Curriculum vitae ..….…………………………………………………………….……………………….....4 II. List of publications ...…..…………………………………………..…………………….…………….....7 III. Scientific supervision ..………………………………………………………………………………….9 IV. Previous research activities Thesis work at EMBL Grenoble (2000-2005) ………………………………………………......................10 Postdoctoral work at the University of Oxford (2005-2007) ………………….……………………………28 V. Current Research EMBL Grenoble (2008-2015) and IBS Grenoble (since 2015) ………………………..………………….38 - PRDM histone methyltransferases ………………………..……………………………………………….39 - Mof acetyltransferase containing complexes ………………………….……………………………….....50 MSL complex ..……..…………………………………………………..……………………………………...50 NSL complex ………..………………………………………………..………………………………………..76 ! 3 I. Curriculum Vitae • PERSONAL INFORMATION Name: KADLEC Jan http://orcid.org/0000-0002-4853-6918 Date of birth: 12.05.1976 Nationality: Czech Married, 2 children Address: Institut de Biologie Structurale (IBS), 71 avenue des Martyrs, CS 10090, 38044 Grenoble Cedex 9, France Tel: 0457428776 E-Mail: [email protected] Website: http://www.ibs.fr/research/research-groups/ebev/epigenetic-regulators • EDUCATION 2001 - 2005 PhD in Structural Biology Joint PhD degree at the European Molecular Biology Laboratory (EMBL) and Université Joseph Fourier in Grenoble, France. 1998 - 2000 Master degree in Molecular Biology, Faculty of Science, Charles University in Prague, Czech Republic. 1995 - 1998 Bachelor degree in Biology, Faculty of Science, Charles University in Prague, Czech Republic. • CURRENT POSITION Since 2015 Team leader - Institut de Biologie Structurale (IBS), Grenoble, France Epigenetic Regulators team Since 2016 Permanent CR1 researcher – INSERM • PROFFESIONAL EXPERIENCE 2009 - 2015 Staff Scientist at EMBL - Grenoble Outstation (with Stephen Cusack) Structural analysis of epigenetic regulators. 2008 Postdoctoral fellow at EMBL - Grenoble Outstation, France (with Stephen Cusack). 2005 - 2007 Postdoctoral fellow - The Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, UK. Structural analysis of viral fusion proteins (with David Stuart). 2001 - 2005 PhD thesis at EMBL - Grenoble Outstation, France. Structural analysis of Nonsense- Mediated mRNA Decay regulators (with Stephen Cusack). 2000 - 2001 Training at EMBL - Grenoble Outstation, France. Structural analysis of the SNARE complex. (with Winfried Weissenhorn). 1998 - 2000 Undergraduate training in the Laboratory of Physiology and Genetics of Actinomycetes at Institute of Microbiology in Prague. Biosynthetic pathways of lincosamid antibiotics (with Jiri Janata) ! 4 • GRANTS AND FELLOWSHIPS 2016 - Labex Gral - Individual projects (120k EUR) 2015 - Fondation ARC - Projet Fondation ARC (50k EUR) 2014 - ATIP/AVENIR start-up grant - CNRS/Plan Cancer (360k EUR+ salary) 2006 - Marie Curie Intra-European postdoctoral fellowship (awarded but declined) 2005 - EMBO long-term postdoctoral fellowship 2001 - Boehringer Ingelheim Fonds PhD scholarship (awarded but declined) 2000 - Fellowship of TEMPRA PECO program of Rhone-Alpes Region, France • TEACHING ACTIVITIES Since 2011 UJF Grenoble, Master 2 course on structural biology - lecture on experimental phasing. 2012 - 2013 EMBL Predoc course - lecture on “Readers and writers of the epigenetic landscape”. • ORGANISATION OF SCIENTIFIC MEETINGS 2013, 2015 Co-organiser of the “Signalling Through Chromatin” international symposium in Grenoble Since 2012 Co-organiser of regular meetings of the Chromatin, Transcription and Epigenetics community of Grenoble. • INSTITUTIONAL RESPONSIBILITIES Since 2016 Co-responsible of the Molecular Medicine research axis at the IBS 2009 - 2015 Faculty member - EMBL 2009 - 2015 Chairing lab committee meetings of the EMBL Grenoble • OTHER SCIENTIFIC ACTIVITIES 2011 - 2016 Editor of the online protocol database of the FP7 EU Network of Excellence ‘Epigenesys’. 2009 - 2013 Provide support to beamline users of the European Synchrotron Radiation Facility (ESRF) • COMMISSIONS OF TRUST 2016 External Grant Evaluator, European Research Council (ERC) 2014 External Grant Evaluator, National Science Center, Poland. Since 2012 Reviewer for PLoS ONE, RNA Biology, Journal of Structural Biology. • MAJOR COLLABORATIONS Asifa Akhtar - Max Planck Institute of Immunobiologie and Epigenetics, Freiburg, Germany. Functional analysis of MOF-containing complexes Bernard de Massy - Institut de Génétique Humaine, Montpellier, France. Functional analysis of PRDM9. • PRESENTATIONS - Central European Institute of Technology (CEITEC), Brno, Czech Republic, 2016, invited speaker - Instruct Workshop on Molecular interactions, Grenoble, 2015, invited speaker - Epigenesys Kick-Off meeting, Paris, France, 2010, invited speaker - VIZIER/Spine2Complexes Joint Workshop on Structural Virology, Vienna, Austria, 2008, invited speaker - 24th European Crystallographic meeting, Marrakech, Morocco, 2007, invited speaker - Structure, Function and Dynamics of RNA-protein Complexes, Gottingen, Germany, 2003, selected speaker ! 5 • SELECTED PUBLICATIONS * Corresponding author Dias, J., Nguyen, N., Georgiev, P., Gaub, A., Brettschneider, J., Cusack, S., Kadlec,
Load more

Recommended publications
  • A Upf3b-Mutant Mouse Model with Behavioral and Neurogenesis Defects
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Mol Psychiatry Manuscript Author . Author Manuscript Author manuscript; available in PMC 2018 September 27. Published in final edited form as: Mol Psychiatry. 2018 August ; 23(8): 1773–1786. doi:10.1038/mp.2017.173. A Upf3b-mutant mouse model with behavioral and neurogenesis defects L Huang1, EY Shum1, SH Jones1, C-H Lou1, J Dumdie1, H Kim1, AJ Roberts2, LA Jolly3,4, J Espinoza1, DM Skarbrevik1, MH Phan1, H Cook-Andersen1, NR Swerdlow5, J Gecz3,4, and MF Wilkinson1,6 1Department of Reproductive Medicine, School of Medicine, University of California, San Diego, La Jolla, California, USA 2Department of Molecular and Cellular Neuroscience, The Scripps Research Institute, 10550 North Torrey Pines Road, MB6, La Jolla, CA 92037, USA 3School Adelaide Medical School and Robison Research Institute, University of Adelaide, Adelaide, SA 5005, Australia 4South Australian Health and Medical Research Institute, Adelaide, SA, 5005, Australia 5Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, California, USA 6Institute of Genomic Medicine, University of California, San Diego, La Jolla, CA Abstract Nonsense-mediated RNA decay (NMD) is a highly conserved and selective RNA degradation pathway that acts on RNAs terminating their reading frames in specific contexts. NMD is regulated in a tissue-specific and developmentally controlled manner, raising the possibility that it influences developmental events. Indeed, loss or depletion of NMD factors have been shown to disrupt developmental events in organisms spanning the phylogenetic scale. In humans, mutations in the NMD factor gene, UPF3B, cause intellectual disability (ID) and are strongly associated with autism spectrum (ASD), attention deficit hyperactivity disorder (ADHD), and schizophrenia (SCZ).
    [Show full text]
  • HHS Public Access Author Manuscript
    HHS Public Access Author manuscript Author Manuscript Author ManuscriptGenet Epidemiol Author Manuscript. Author Author Manuscript manuscript; available in PMC 2016 June 01. Published in final edited form as: Genet Epidemiol. 2015 December ; 39(8): 664–677. doi:10.1002/gepi.21932. Multiple SNP-sets Analysis for Genome-wide Association Studies through Bayesian Latent Variable Selection Zhaohua Lu, Hongtu Zhu, Rebecca C Knickmeyer, Patrick F. Sullivan, Williams N. Stephanie, and Fei Zou for the Alzheimer’s Disease Neuroimaging Initiative* Departments of Biostatistics, Psychiatry, and Genetics and Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA Abstract The power of genome-wide association studies (GWAS) for mapping complex traits with single SNP analysis may be undermined by modest SNP effect sizes, unobserved causal SNPs, correlation among adjacent SNPs, and SNP-SNP interactions. Alternative approaches for testing the association between a single SNP-set and individual phenotypes have been shown to be promising for improving the power of GWAS. We propose a Bayesian latent variable selection (BLVS) method to simultaneously model the joint association mapping between a large number of SNP-sets and complex traits. Compared to single SNP-set analysis, such joint association mapping not only accounts for the correlation among SNP-sets, but also is capable of detecting causal SNP- sets that are marginally uncorrelated with traits. The spike-slab prior assigned to the effects of SNP-sets can greatly reduce the dimension of effective SNP-sets, while speeding up computation. An efficient MCMC algorithm is developed. Simulations demonstrate that BLVS outperforms several competing variable selection methods in some important scenarios.
    [Show full text]
  • UPF3A Rabbit Pab
    Leader in Biomolecular Solutions for Life Science UPF3A Rabbit pAb Catalog No.: A15893 Basic Information Background Catalog No. This gene encodes a protein that is part of a post-splicing multiprotein complex involved A15893 in both mRNA nuclear export and mRNA surveillance. The encoded protein is one of two functional homologs to yeast Upf3p. mRNA surveillance detects exported mRNAs with Observed MW truncated open reading frames and initiates nonsense-mediated mRNA decay (NMD). 55kDa When translation ends upstream from the last exon-exon junction, this triggers NMD to degrade mRNAs containing premature stop codons. This protein binds to the mRNA and Calculated MW remains bound after nuclear export, acting as a nucleocytoplasmic shuttling protein. It 17kDa/51kDa/54kDa forms with Y14 a complex that binds specifically 20 nt upstream of exon-exon junctions. This gene is located on the long arm of chromosome 13. Two splice variants encoding Category different isoforms have been found for this gene. Primary antibody Applications WB,IF Cross-Reactivity Human, Mouse, Rat Recommended Dilutions Immunogen Information WB 1:500 - 1:2000 Gene ID Swiss Prot 65110 Q9H1J1 IF 1:50 - 1:200 Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 327-476 of human UPF3A (NP_075387.1). Synonyms UPF3A;HUPF3A;RENT3A;UPF3 Contact Product Information www.abclonal.com Source Isotype Purification Rabbit IgG Affinity purification Storage Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide,50% glycerol,pH7.3. Validation Data Western blot analysis of extracts of mouse testis, using UPF3A antibody (A15893) at 1:1000 dilution.
    [Show full text]
  • UC Berkeley UC Berkeley Electronic Theses and Dissertations
    UC Berkeley UC Berkeley Electronic Theses and Dissertations Title Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD Permalink https://escholarship.org/uc/item/4md923q7 Author Desai, Anna Publication Date 2017 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD by Anna Maria Desai A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Comparative Biochemistry in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Steven E. Brenner, Chair Professor Donald Rio Professor Lin He Fall 2017 Abstract Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD by Anna Maria Desai Doctor of Philosophy in Comparative Biochemistry University of California, Berkeley Professor Steven E. Brenner, Chair Virtually all multi-exon genes undergo alternative splicing (AS) to generate multiple protein isoforms. Alternative splicing is regulated by splicing factors, such as the serine/arginine rich (SR) protein family and the heterogeneous nuclear ribonucleoproteins (hnRNPs). Splicing factors are essential and highly conserved. It has been shown that splicing factors modulate alternative splicing of their own transcripts and of transcripts encoding other splicing factors. However, the extent of this alternative splicing regulation has not yet been determined. I hypothesize that the splicing factor network extends to many SR and hnRNP proteins, and is regulated by alternative splicing coupled to the nonsense mediated mRNA decay (NMD) surveillance pathway. The NMD pathway has a role in preventing accumulation of erroneous transcripts with dominant negative phenotypes.
    [Show full text]
  • ALS Mutations of FUS Suppress Protein Translation and Disrupt the Regulation of Nonsense-Mediated Decay
    ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay Marisa Kamelgarna, Jing Chenb, Lisha Kuangb, Huan Jina, Edward J. Kasarskisa,c, and Haining Zhua,b,d,1 aDepartment of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536; bDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40536; cDepartment of Neurology, College of Medicine, University of Kentucky, Lexington, KY 40536; and dLexington VA Medical Center, Research and Development, Lexington, KY 40502 Edited by Gregory A. Petsko, Weill Cornell Medical College, New York, NY, and approved October 22, 2018 (received for review June 16, 2018) Amyotrophic lateral sclerosis (ALS) is an incurable neurodegener- This study started with testing the hypothesis that the identi- ative disease characterized by preferential motor neuron death. fication of proteins associated with mutant FUS-dependent cy- Approximately 15% of ALS cases are familial, and mutations in the toplasmic granules is likely to provide critical insights into the fused in sarcoma (FUS) gene contribute to a subset of familial ALS toxic mechanism of mutant FUS. We developed a protocol to cases. FUS is a multifunctional protein participating in many RNA capture the dynamic mutant FUS-positive granules (3, 4) by metabolism pathways. ALS-linked mutations cause a liquid–liquid membrane filtration and identified protein components by pro- phase separation of FUS protein in vitro, inducing the formation of teomic approaches. The bioinformatics analysis of proteins cytoplasmic granules and inclusions. However, it remains elusive identified in wild-type (WT) and mutant FUS granules revealed what other proteins are sequestered into the inclusions and how multiple RNA metabolism pathways, among which protein such a process leads to neuronal dysfunction and degeneration.
    [Show full text]
  • Messenger-Rna-Binding Proteins and the Messages They Carry
    REVIEWS MESSENGER-RNA-BINDING PROTEINS AND THE MESSAGES THEY CARRY Gideon Dreyfuss*, V.Narry Kim‡ and Naoyuki Kataoka* From sites of transcription in the nucleus to the outreaches of the cytoplasm, messenger RNAs are associated with RNA-binding proteins. These proteins influence pre-mRNA processing as well as the transport, localization, translation and stability of mRNAs. Recent discoveries have shown that one group of these proteins marks exon–exon junctions and has a role in mRNA export. These proteins communicate crucial information to the translation machinery for the surveillance of nonsense mutations and for mRNA localization and translation. PRE-mRNA To function properly, eukaryotic messenger RNAs must Recent discoveries showed that this mature mRNP The primary transcript of the contain, in addition to a string of codons, information contains proteins that it acquired strictly in the wake of genomic DNA, which contains that specifies their nuclear export, subcellular localiza- the splicing reaction. These proteins, which are exons, introns and other tion, translation and stability. An important theme to arranged in the form of a complex called the exon–exon sequences. emerge over the past few years is that much of this infor- junction complex (EJC), mark the position of SPLICING mation is provided by specific RNA-binding proteins. exon–exon junctions. EJC proteins have a role in the The removal of introns from the These proteins — collectively referred to as heteroge- nuclear export of mRNAs that are produced by splicing, pre-mRNA. neous nuclear ribonucleoproteins (hnRNP proteins) and several of the mRNP’s components persist in the or mRNA–protein complex proteins (mRNP pro- same position after export of the mRNP to the cyto- TERMINATION CODONS The stop signals for translation: teins) — are PRE-mRNA/mRNA-binding proteins that plasm.
    [Show full text]
  • UPF3A and UPF3B Are Redundant and Modular Activators of Nonsense-Mediated Mrna Decay in Human Cells
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.07.451444; this version posted July 13, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 UPF3A and UPF3B are redundant and modular activators of 2 nonsense-mediated mRNA decay in human cells 3 4 Damaris Wallmeroth1,2, Volker Boehm1,2, Jan-Wilm Lackmann3, Janine Altmüller4,5, Christoph 5 Dieterich6,7, Niels H. Gehring1,2 6 7 1 Institute for Genetics, University of Cologne, 50674 Cologne, Germany 8 2 Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50937 Cologne, 9 Germany 10 3 CECAD Research Center, University of Cologne, Joseph-Stelzmann-Str. 26, 50931 11 Cologne, Germany 12 4 Cologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany 13 5 Present address: Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Core 14 Facility Genomics, Charitéplatz 1, 10117 Berlin, Germany and Max Delbrück Center for 15 Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany 16 6 Section of Bioinformatics and Systems Cardiology, Department of Internal Medicine III and 17 Klaus Tschira Institute for Integrative Computational Cardiology, Heidelberg University 18 Hospital, 69120 Heidelberg, Germany 19 7 DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 20 69120 Heidelberg, Germany 21 22 *Correspondence: [email protected] (V.B.), [email protected] (N.H.G.) 23 24 Keywords 25 Nonsense-mediated mRNA decay, gene paralogs, mRNA turnover, UPF3 26 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.07.451444; this version posted July 13, 2021.
    [Show full text]
  • A Novel Ribosomopathy Caused by Dysfunction of RPL10 Disrupts Neurodevelopment and Causes X-Linked Microcephaly in Humans
    HIGHLIGHTED ARTICLE INVESTIGATION A Novel Ribosomopathy Caused by Dysfunction of RPL10 Disrupts Neurodevelopment and Causes X-Linked Microcephaly in Humans Susan S. Brooks,*,1 Alissa L. Wall,†,1 Christelle Golzio,† David W. Reid,‡ Amalia Kondyles,† Jason R. Willer,† Christina Botti,* Christopher V. Nicchitta,‡,§ Nicholas Katsanis,† and Erica E. Davis†,2 *Department of Pediatrics, Rutgers Biomedical and Health Sciences, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, and †Center for Human Disease Modeling, ‡Department of Biochemistry, and §Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710 ORCID IDs: 0000-0002-1618-7127 (S.B.); 0000-0002-2412-8397 (E.D.) ABSTRACT Neurodevelopmental defects in humans represent a clinically heterogeneous group of disorders. Here, we report the genetic and functional dissection of a multigenerational pedigree with an X-linked syndromic disorder hallmarked by microcephaly, growth retardation, and seizures. Using an X-linked intellectual disability (XLID) next-generation sequencing diagnostic panel, we identified a novel missense mutation in the gene encoding 60S ribosomal protein L10 (RPL10), a locus associated previously with autism spectrum disorders (ASD); the p.K78E change segregated with disease under an X-linked recessive paradigm while, consistent with causality, carrier females exhibited skewed X inactivation. To examine the functional consequences of the p.K78E change, we modeled RPL10 dysfunction in zebrafish. We show that endogenous rpl10 expression is augmented in anterior structures, and that suppression decreases head size in developing morphant embryos, concomitant with reduced bulk translation and increased apoptosis in the brain. Subsequently, using in vivo complementation, we demonstrate that p.K78E is a loss-of-function variant.
    [Show full text]
  • UPF3A Antibody Cat
    UPF3A Antibody Cat. No.: 16-307 UPF3A Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Mouse Recombinant fusion protein containing a sequence corresponding to amino acids 327-476 IMMUNOGEN: of human UPF3A (NP_075387.1). TESTED APPLICATIONS: WB APPLICATIONS: WB: ,1:500 - 1:2000 POSITIVE CONTROL: 1) Mouse testis PREDICTED MOLECULAR Observed: 55kDa WEIGHT: Properties PURIFICATION: Affinity purification CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid September 23, 2021 1 https://www.prosci-inc.com/upf3a-antibody-16-307.html BUFFER: PBS with 0.02% sodium azide, 50% glycerol, pH7.3. STORAGE CONDITIONS: Store at -20˚C. Avoid freeze / thaw cycles. Additional Info OFFICIAL SYMBOL: UPF3A UPF3A, UPF3 regulator of nonsense transcripts homolog A, OTTHUMP00000018789, UPF3, ALTERNATE NAMES: RENT3A, HUPF3A, UPF3 regulator of nonsense transcripts homolog A (yeast), UPF3A GENE ID: 65110 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References This gene encodes a protein that is part of a post-splicing multiprotein complex involved in both mRNA nuclear export and mRNA surveillance. The encoded protein is one of two functional homologs to yeast Upf3p. mRNA surveillance detects exported mRNAs with truncated open reading frames and initiates nonsense-mediated mRNA decay (NMD). When translation ends upstream from the last exon-exon junction, this triggers NMD to BACKGROUND: degrade mRNAs containing premature stop codons. This protein binds to the mRNA and remains bound after nuclear export, acting as a nucleocytoplasmic shuttling protein. It forms with Y14 a complex that binds specifically 20 nt upstream of exon-exon junctions. This gene is located on the long arm of chromosome 13.
    [Show full text]
  • RNA-Seq Analysis Reveals Localization-Associated Alternative Splicing Across 13 Cell Lines
    G C A T T A C G G C A T genes Article RNA-Seq Analysis Reveals Localization-Associated Alternative Splicing across 13 Cell Lines Chao Zeng 1,2,* and Michiaki Hamada 1,2,3,4,* 1 AIST-Waseda University Computational Bio Big-Data Open Innovation Laboratory (CBBD-OIL), Tokyo 169-8555, Japan 2 Faculty of Science and Engineering, Waseda University, Tokyo 169-8555, Japan 3 Institute for Medical-oriented Structural Biology, Waseda University, Tokyo 162-8480, Japan 4 Graduate School of Medicine, Nippon Medical School, Tokyo 113-8602, Japan * Correspondence: [email protected] (C.Z.); [email protected] (M.H.) Received: 19 June 2020; Accepted: 17 July 2020; Published: 18 July 2020 Abstract: Alternative splicing, a ubiquitous phenomenon in eukaryotes, is a regulatory mechanism for the biological diversity of individual genes. Most studies have focused on the effects of alternative splicing for protein synthesis. However, the transcriptome-wide influence of alternative splicing on RNA subcellular localization has rarely been studied. By analyzing RNA-seq data obtained from subcellular fractions across 13 human cell lines, we identified 8720 switching genes between the cytoplasm and the nucleus. Consistent with previous reports, intron retention was observed to be enriched in the nuclear transcript variants. Interestingly, we found that short and structurally stable introns were positively correlated with nuclear localization. Motif analysis reveals that fourteen RNA-binding protein (RBPs) are prone to be preferentially bound with such introns. To our knowledge, this is the first transcriptome-wide study to analyze and evaluate the effect of alternative splicing on RNA subcellular localization.
    [Show full text]
  • UPF1 in Nonsense-Mediated Mrna Decay and Beyond
    Downloaded from rnajournal.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW UPFront and center in RNA decay: UPF1 in nonsense- mediated mRNA decay and beyond YOON KI KIM1,2 and LYNNE E. MAQUAT3,4 1Creative Research Initiatives Center for Molecular Biology of Translation, Korea University, Seoul 02841, Republic of Korea 2Division of Life Sciences, Korea University, Seoul 02841, Republic of Korea 3Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, New York 14642, USA 4Center for RNA Biology, University of Rochester, Rochester, New York 14642, USA ABSTRACT Nonsense-mediated mRNA decay (NMD), which is arguably the best-characterized translation-dependent regulatory path- way in mammals, selectively degrades mRNAs as a means of post-transcriptional gene control. Control can be for the pur- pose of ensuring the quality of gene expression. Alternatively, control can facilitate the adaptation of cells to changes in their environment. The key to NMD, no matter what its purpose, is the ATP-dependent RNA helicase upstream frameshift 1 (UPF1), without which NMD fails to occur. However, UPF1 does much more than regulate NMD. As examples, UPF1 is en- gaged in functionally diverse mRNA decay pathways mediated by a variety of RNA-binding proteins that include staufen, stem–loop-binding protein, glucocorticoid receptor, and regnase 1. Moreover, UPF1 promotes tudor-staphylococcal/ micrococcal-like nuclease-mediated microRNA decay. In this review, we first focus on how the NMD machinery recognizes an NMD target and triggers mRNA degradation. Next, we compare and contrast the mechanisms by which UPF1 functions in the decay of other mRNAs and also in microRNA decay.
    [Show full text]
  • Harnessing Gene Discovery and Cellular Models to Understand the Genetics Underlying Neurodevelopmental Disorders Dr
    February 2016 Harnessing Gene Discovery and Cellular Models to Understand the Genetics Underlying Neurodevelopmental Disorders Dr. Lachlan Jolly and his team at the University of Adelaide are applying functional genomic methods to identify the role of UPF3B and HCFC1 in intellectual disability. Introduction Living in Australia, Lachlan Jolly, PhD, takes advantage of everything the outdoors has to offer. When Dr. Jolly is not cycling, surfing, hiking, or playing basketball, he’s involved with equally expansive research programs to identify and study genes responsible for neurological disorders. To discover novel gene variants and describe their role in intellectual disability, Dr. Jolly integrates cell-based models with a multitude of genetic and functional genomic technologies. As an Australian Research Council Fellow at the University of Adelaide, Dr. Jolly has a leading role in the Neurogenetics Research Program. While other groups identify gene variants underlying neurodevelopmental disorders, Dr. Jolly directs research to discover Lachlan Jolly, Ph.D. is an Australian Research Council Fellow at the effects of genetic change. “We want to know what functional effect the University of Adelaide, where he focuses on understanding gene variants have in the development of the brain,” Dr. Jolly said. “We the genetic networks involved in brain development and function. know that they cause human disorders, but we want to know how they affect the way the cells behave and communicate.” The group genomics assays suggested involvement of a noncoding variant in the uses next-generation sequencing (NGS) to identify novel mutations, HCFC1 gene.3 and cell culture models of embryonic neural development to gain insight into novel genetic networks important for brain development Q: What can we learn about brain development from using different and function.
    [Show full text]